SESinan Eliaçık

Sinan Eliaçık

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sinan Eliaçık has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    3D CNN-CVAE and LSTM-guided de novo design of rotigotine derivatives targeting dopamine D1 and D3 receptors in restless legs syndrome

    by Sinan Eliaçık, Nouman Ali

    Restless legs syndrome (RLS) is a chronic neurological disorder associated with altered dopaminergic signaling, while long-term dopamine agonist therapy may be limited by augmentation and reduced clinical benefit. This study applied a three-dimensional convolutional neural network conditional variational autoencoder integrated with long short-term memory molecular generation to design rotigotine-derived candidates targeting dopamine D1 and D3 receptors. Fourteen unique derivatives were generated and screened through pocket prediction, molecular docking, interaction profiling, pharmacophore analysis, density functional theory, ADMET prediction, 500 ns molecular dynamics simulations performed in explicit water without a lipid bilayer, and MM/GBSA calculations. Docking protocol validation using DockRMSD yielded RMSD values of 1.009 Å for Mevidalen in the D1 receptor and 1.359 Å for PD-128907 in the D3 receptor, supporting acceptable reproduction of both experimental binding poses. In docking-based ranking, AI Derivative 1 was placed above rotigotine for D1 (−5.744 vs −5.629 kcal/mol) and D3 (−7.934 vs −7.288 kcal/mol) and formed additional hydrogen-bond and hydrophobic contacts; the D1 difference of approximately 0.1 kcal/mol lies within the intrinsic uncertainty of docking scoring functions and is not interpreted as evidence of improved affinity. Docking scores are used throughout as ranking and prioritization metrics rather than quantitative binding free energies. It also exhibited a smaller HOMO-LUMO gap, a higher predicted LD 50 , and a shift from toxicity class 3 to class 4. Molecular dynamics analyses, including RMSD, RMSF, radius of gyration, solvent-accessible surface area, hydrogen bonding, DCCM, PCA, and free-energy landscapes, are reported as descriptive observations from single non-membrane trajectories and are not used to claim physiological relevance or superior binding stability. MM/GBSA estimates were favorable under the applied computational conditions. AI Derivative 1 therefore represents a computationally prioritized lead requiring experimental validation.


  • Open Access

    Intractable hiccups as a brainstem red flag: demyelinating disorders with emphasis on neuromyelitis optica spectrum disorder and area postrema syndrome

    by Sinan Eliaçık

    Background: Persistent and intractable hiccups may indicate brainstem pathology rather than benign gastrointestinal causes. Among inflammatory demyelinating disorders, neuromyelitis optica spectrum disorder (NMOSD) frequently involves the dorsal medulla, particularly the area postrema, a key structure in the hiccup reflex arc. Area postrema syndrome (APS), characterized by otherwise unexplained hiccups, nausea, or vomiting lasting ≥ 48 h, represents a core diagnostic feature of NMOSD. Methods: A structured narrative literature review was conducted using PubMed, Scopus, and Web of Science databases from inception to January 2026. Studies addressing persistent or intractable hiccups associated with demyelinating disorders, including NMOSD, multiple sclerosis, and myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), were analyzed with emphasis on neuroanatomical, immunopathological, and radiological correlations. Results: NMOSD is the prototypical demyelinating disorder associated with intractable hiccups due to selective astrocytic injury in the area postrema. APS may precede optic neuritis or myelitis and can represent the initial manifestation of disease. Multiple sclerosis and MOGAD may also involve the brainstem but differ in lesion distribution, immunopathology, and treatment implications. Early recognition of dorsal medullary involvement and antibody testing is critical for accurate diagnosis and timely immunotherapy. Conclusion: Intractable hiccups should be recognized as a potential brainstem red flag symptom. Awareness of their association with NMOSD and related demyelinating disorders facilitates early diagnosis, appropriate immunotherapy, and prevention of neurological disability.

  • Open Access

    The hidden face of transient ischemic attack: Increased superstitious belief and psychiatric comorbidity

    by Sinan Eliaçık, Ayşe Erdoğan Kaya

    Objective: Transient ischemic attack (TIA) is a warning event for ischemic stroke and may be accompanied by psychological sequelae. While depression and anxiety following TIA have been increasingly recognized, changes in superstitious beliefs after TIA have not been systematically investigated. This study aimed to evaluate depression, anxiety, and superstitious beliefs in patients with TIA compared with healthy controls and to examine their clinical correlates. Materials and Methods: This cross-sectional observational study included 220 patients with a history of TIA and 200 age- and sex-matched healthy controls. Participants completed the Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), and the Superstition Scale (SS) during the first-month follow-up after TIA. Comparisons were performed between groups and according to TIA symptom characteristics. Multivariate linear regression analysis was conducted to identify independent predictors of superstitious beliefs. Results: Patients with TIA had significantly higher BDI, BAI, and SS scores compared with controls (P

  • Open Access

    Anti-Seizure Drug Discontinuation in Individuals with Epilepsy: Single-Centre Experiences — When, How Long, How?

    by Sinan Eliaсık

    Aims: The present study aimed to evaluate seizure recurrence rates after anti-seizure medication (ASM) discontinuation in adults with epilepsy and to identify clinical and treatment-related factors associated with relapse. Study Design: Retrospective observational single-center study. Place and Duration of Study: This study was conducted at the Department of Neurology, Hitit University Faculty of Medicine Hospital. Patient data collected between December 2013 and January 2025 were retrospectively analyzed. Methodology: Adult patients with epilepsy who had been seizure-free for at least 2 years and whose ASM therapy was gradually discontinued under neurologist supervision were included. Only patients with normal neurological examination findings, normal cranial Magnetic Resonance Imaging (MRI), and regular follow-up data were analyzed. Demographic characteristics, age at onset, seizure type, duration of seizure-free period prior to discontinuation, treatment modality (monotherapy vs polytherapy), Electroencephalography (EEG) findings before withdrawal, tapering duration, and seizure recurrence were evaluated. Results: Out of 1,538 epilepsy patient files reviewed, ASM therapy was discontinued in 424 patients (27.6%). The cohort included 189 females (44.6%) and 235 males (55.4%), with a mean age of 46.8±15.2 years. Seizure recurrence occurred in 88 patients (20.8%) either during dose reduction or after complete withdrawal. Recurrence was significantly associated with shorter seizure-free duration, polytherapy, abnormal EEG findings, and shorter tapering periods. Conclusion: ASM discontinuation is a critical stage in epilepsy management and remains a complex clinical decision. Individualized withdrawal strategies considering clinical risk factors may help reduce relapse rates and improve long-term outcomes.

  • Vestibular Migraine and Rehabilitation

    by Sinan Eliaçık, Funda Uysal Tan

  • Vestibular Migraine and Rehabilitation

    by Sinan Eliaçık, Funda Uysal Tan

  • Relationship Between Dysmenorrhea and Migraine and Their Effect on Employees' Health Behavior and Daily Life Functions

    by Sinan Eliaçık

    Objective: Female employees in organizations face health-related challenges when they face issues related to dysmenorrhea and migraine, and it becomes difficult for them to maintain their work performance. The objective of this study was to measure the impact of the frequency of dysmenorrhea, severity of migraine and coping mechanisms on the work loss and daily life functioning of the employees. The study also tested the mediating role of quality of life between the relationship of these variables. Method: A sample of 177 female employees from different firms was selected. The data was collected through a structured survey questionnaire. Intervention: The empirical tests were performed using RStudio software, considered appropriate for confirmatory factor analysis and structural equation modelling. Results: The study found that the impact of the frequency of dysmenorrhea, severity of migraine and coping mechanisms on the work loss and daily life functioning of the employees was significant and positively indirect. The mediating role of quality of life was also positively accepted between the direct relationships. Conclusion: The study is novel as it contributed significant knowledge to the literature body. The practical findings of this research are also essential to improve the female employees' daily functioning and work loss.

  • Open Access

    Impact of Behavioral and Psychological Symptoms of Dementia (BPSD) on Caregiver Mental Health

    by Binnur Özkar, Sinan Eli̇aÇik

    Background: Behavioral and psychological symptoms of dementia (BPSD) are very common and are identified to be the major causes of distress among caregivers. Although much research has been made on cognitive impairment in dementia, less attention has been given to the effect of neuropsychiatric symptoms on the mental health of caregivers, such as depression, anxiety, and perceived burden. This paper attempted to determine the correlation between the severity of BPSD and caregiver psychological outcome and the identification of the critical sociodemographic and caregiving-associated factors that predict caregiver distress. Methods: A cross sectional study was done among 120 primary caregivers of patients with clinically diagnosed dementia who were identified in neurology and geriatric outpatient clinics. Behavioral and psychological symptoms were evaluated through the Neuropsychiatric Inventory (NPI), whereas the caregiver outcomes were evaluated through the Patient Health Questionnaire-9 (PHQ-9) scale of depression, the Generalized Anxiety Disorder-7 (GAD-7) scale of anxiety, and the Zarit Burden Interview (ZBI) scale of caregiver burden. Sociodemographic and care giving variables, such as age, gender, relationship with the patient, duration, and number of hours of care giving per day, were collected. Correlation, multivariate regression and interaction analyses were used as the statistical analyses. Visualizations of associations were done using advanced graphical analyses, such as regression overlays and interaction plots. Results: The average total NPI score was 34.6246.15, which represented a moderate level of BPSD burden. The BPSD domains that were the most prevalent were agitation/aggression (62.5%), depression/dysphoria (58.3%), and anxiety (55.8%). In caregivers, the levels of depression (PHQ-9: 11.2 ± 5.6), anxiety (GAD-7: 9.6 ± 4.8), and moderate-severe burden (ZBI: 38.4 ± 14.2) were moderate. Caregiver depression (r = 0.61), anxiety (r = 0.58) and burden (r = 0.67; p < 0.001 all) were positively correlated with total BPSD severity. Multivariate regression analysis revealed that the severity of BPSD, female gender, spousal relationship, extended period of care giving, and more hours of daily care giving were important predictors of caregiver distress. The analysis of interactions revealed that female caregivers were disproportionately higher burdened with increase in BPSD severity. The overlays that were confirmed through regression showed strong linear relationships between NPI scores and caregiver psychological outcomes. Conclusion: Dementia behavioral and psychological symptoms are a serious threat to the mental health of the caregivers, and the symptoms of agitation, depressive symptoms, and sleeping problems are the main reasons. The female and spousal caregivers, and those giving long-term and intensive care, are highly susceptible. These results indicate that combined, caregiver-based dementia care approaches that are sensitive to the effects of neuropsychiatric symptoms of patients and psychological support of caregivers are necessary. To enhance patient and caregiver outcomes, it is necessary to identify high-risk caregivers at an early stage and implement interventions to improve outcomes